Squarepoint Ops LLC reports 28.44% increase in ownership of BSFA / ANI Pharmaceuticals, Inc.

ANI 製藥公司

DE ˙ DB ˙ US00182C1036

€54.50 0.00 (0.00%)

2023-08-21
分享價格

Security	DE:BSFA / ANI Pharmaceuticals, Inc.
Institution	Squarepoint Ops LLC
Latest Disclosed Ownership	63,538 shares
Latest Disclosed Value	$ 4,886,072

On May 15, 2026 - Squarepoint Ops LLC filed a 13F-HR form disclosing ownership of 63,538 shares of ANI Pharmaceuticals, Inc. (DE:BSFA) valued at $4,886,072 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 49,468 shares of ANI Pharmaceuticals, Inc.. This represents a change in shares of 28.44% during the quarter. The current value of the position is $3,462,821 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-05-15	2026-03-31	13F	ANI PHARMACEUTICALS	COM	00182C103	63,538	14,070	28.44	4,886	25.12	0.0057
2026-02-13	2025-12-31	13F	ANI PHARMACEUTICALS	COM	00182C103	49,468	-24,175	-32.83	3,905	-42.11	0.0042
2025-11-14	2025-09-30	13F	ANI PHARMACEUTICALS	COM	00182C103	73,643	40,899	124.91	6,746	215.78	0.0068
2025-08-27	2025-06-30	13F/A-1	ANI PHARMACEUTICALS	COM	00182C103	32,744	32,744		2,137		0.0022
2025-08-14	2025-06-30	13F	ANI PHARMACEUTICALS	COM	00182C103	32,744	32,744		2,137		0.0022
2022-02-14	2021-12-31	13F	ANI PHARMACEUTICALS	COM	00182C103	0	-14,882	-100.00	0	-100.00
2021-11-15	2021-09-30	13F	ANI PHARMACEUTICALS	COM	00182C103	14,882	-5,850	-28.22	488	-32.87	0.0014
2021-08-16	2021-06-30	13F	ANI PHARMACEUTICALS	COM	00182C103	20,732	7,580	57.63	727	53.05	0.0028
2021-05-17	2021-03-31	13F	ANI PHARMACEUTICALS	COM	00182C103	13,152	13,152		475		0.0028
2020-11-16	2020-09-30	13F	ANI PHARMACEUTICALS	COM	00182C103	0	-6,842	-100.00	0	-100.00
2020-08-14	2020-06-30	13F	ANI PHARMACEUTICALS	COM	00182C103	6,842	6,842		221		0.0036
2020-05-15	2020-03-31	13F	ANI PHARMACEUTICALS	COM	00182C103	0	-15,810	-100.00	0	-100.00
2020-02-14	2019-12-31	13F	ANI PHARMACEUTICALS	COM	00182C103	15,810	15,810		975		0.0058
2019-11-14	2019-09-30	13F	ANI PHARMACEUTICALS	COM	00182C103	0	-17,372	-100.00	0	-100.00
2019-08-14	2019-06-30	13F	ANI PHARMACEUTICALS	COM	00182C103	17,372	8,830	103.37	1,428	136.82	0.0139
2019-05-15	2019-03-31	13F	ANI PHARMACEUTICALS	COM	00182C103	8,542	-6,030	-41.38	603	-8.08	0.0064
2019-02-14	2018-12-31	13F	ANI PHARMACEUTICALS	COM	00182C103	14,572	14,572		656		0.0076
2018-08-14	2018-06-30	13F	ANI PHARMACEUTICALS	COM	00182C103	0	-3,796	-100.00	0	-100.00
2018-05-15	2018-03-31	13F	ANI PHARMACEUTICALS	COM	00182C103	3,796	-16,954	-81.71	221	-83.47	0.0035
2018-02-14	2017-12-31	13F	ANI PHARMACEUTICALS	COM	00182C103	20,750	20,750		1,337		0.0233
2017-11-14	2017-09-30	13F	ANI PHARMACEUTICALS	COM	00182C103	0	-6,097	-100.00	0	-100.00
2017-08-14	2017-06-30	13F	ANI PHARMACEUTICALS	COM	00182C103	6,097	6,097		285		0.0056
2017-05-15	2017-03-31	13F	ANI PHARMACEUTICALS	COM	00182C103	0	-4,088	-100.00	0	-100.00
2017-02-14	2016-12-31	13F	ANI PHARMACEUTICALS	COM	00182C103	4,088	184	4.71	248	-4.25	0.0101
2016-11-14	2016-09-30	13F	ANI PHARMACEUTICALS	COM	00182C103	3,904	3,904	0.00	259		0.0172
2016-08-15	2016-06-30	13F	ANI PHARMACEUTICALS	COM	00182C103	0	-18,645	-100.00	0	-100.00
2016-05-16	2016-03-31	13F	ANI PHARMACEUTICALS	COM	00182C103	18,645	7,700	70.35	628	27.13	0.0487
2016-02-16	2015-12-31	13F	ANI PHARMACEUTICALS	COM	00182C103	10,945	10,945		494		0.0542

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.